Target intelligence / Profile preview

Torsin family 4 member A (TOR4A)

Target
TOR4A
Molecular classification
Other, AAA+ ATPase family, P-loop containing nucleoside triphosphate hydrolase
01

Overview

Torsin family 4 member A (TOR4A) is a human protein encoded by the TOR4A gene located on chromosome 9. It is part of the AAA+ (ATPases Associated with diverse cellular Activities) protein superfamily and is predicted to have ATP binding and ATP hydrolysis activities[9][10][1]. TOR4A is primarily localized in the cytoplasm, endomembrane system, endoplasmic reticulum lumen, and nuclear envelope[1][5]. Its precise biological function in humans is not well defined, but as a member of the torsin family, it may play a role in intracellular trafficking, membrane dynamics, or cellular stress responses—a general property of torsin/AAA+ proteins. There is currently no evidence that TOR4A is a therapeutic target, is implicated in major disease roles, or interacts with known drugs[9][10][6]. Essential context and curation details: - The canonical name is "Torsin family 4 member A" (not "torsin-4A" or "C9orf167"); the most widely accepted abbreviation is TOR4A[9][10]. - Aliases include Torsin-4A, C9orf167, FLJ20245, and torsin family protein C9orf167[9][10]. - Protein family: It belongs to the AAA+ ATPase family and contains P-loop nucleoside triphosphate hydrolase domains[1][6]. - Function & localization: The protein binds and hydrolyzes ATP, with localization to the endoplasmic reticulum and nuclear envelope, similar to other torsin proteins[1][5]. - Disease relevance: No direct implication in major disease pathways, no well-established disease roles, and not a recognized biomarker or therapeutic target as per current literature and databases[9][10][6]. - Interactions/drugs/mechanism/safety: No documented interacting drugs, mechanisms of drug action, or specific safety concerns; these sections remain null or unknown based on current data. Limitations: There are limited functional and clinical data on TOR4A in the public domain. As of this search, most annotations are based on homology, predicted structure, and broad protein family classification[10][9][1][6]. No information supports TOR4A as a regulatory receptor, enzyme, or direct therapeutic target. References used for curation: Information has been synthesized from UniProt, NCBI Gene, EMBL-EBI InterPro, Alliance Genome Resources, and The Human Protein Atlas[10][9][6][1][5][2].

Other names
Torsin-4AC9orf167FLJ20245torsin family protein C9orf167
02

Biological functions

ATP bindingATP hydrolysisLikely involved in endomembrane system/ER and nuclear envelope homeostasis
03

Disease associations

Other

Beyond the preview

Go deeper on Torsin family 4 member A (TOR4A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Torsin family 4 member A (TOR4A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call